Select Medical Signs Definitive Merger Agreement at $16.50/Share; Q1 Revenue Up 5%, EPS Declines
SEM sits 41% above its 52-week low of $11.65.
Summary
Select Medical Holdings Corp announced it has signed a definitive merger agreement to be acquired for $16.50 per share, with the transaction expected to close mid-2026. This definitive agreement follows a previously disclosed take-private proposal from the Executive Chairman, marking a significant advancement in the transaction. Concurrently, the company reported mixed first-quarter 2026 results, with revenue increasing 5% year-over-year to $1.42 billion, driven by strength in rehab and outpatient segments. However, net income declined 22.4% to $44 million and diluted EPS fell 20.5% to $0.35, with Adjusted EBITDA also down 6.5% due to rising personnel costs. The signed merger agreement provides a clear valuation and exit for shareholders, with the stock currently trading very close to the offer price, indicating high market confidence in the deal's completion. Traders will now primarily focus on regulatory approvals and the closing timeline for the merger, as operational performance becomes less relevant given the impending acquisition.
At the time of this announcement, SEM was trading at $16.41 on NYSE in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $11.65 to $18.53. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.